| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 03/18/2004 | US20040053951 Non-peptide GnRH agents, pharmaceutical compositions, and methods for their use |
| 03/18/2004 | US20040053945 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053924 Reacting pyrrolo(2,3-d)pyrimidin-4-one derivative containing a leaving group with a aromatic or heteroaromatic amine, hydroxy, marcaptan etc. in presence of a polar solvent and a catalyst |
| 03/18/2004 | US20040053921 Compounds useful as reversible inhibitors of cysteine proteases |
| 03/18/2004 | US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 03/18/2004 | US20040053898 For organ specific therapy; for treatment of menopausal symptoms, hormone-deficiency diseases and neurodegenerative diseases |
| 03/18/2004 | US20040053853 Topiramate salts and compositions comprising and methods of making and using the same |
| 03/18/2004 | US20040053842 Cholesterol ester transfer protein inhibitors for use in treating atherosclerosis optionally in combination with other antihypertensive agents |
| 03/18/2004 | US20040053833 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 03/18/2004 | US20040053828 Partial peptide mimetics and methods |
| 03/18/2004 | US20040053357 Nucleic acid encoding kv10.1 a voltage-gated potassium channel from human brain |
| 03/18/2004 | US20040053325 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 03/18/2004 | US20040052787 Screening for menstruation disorders; measurement nucleic acids or protein |
| 03/18/2004 | CA2497901A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | CA2497497A1 Regulators for implantation |
| 03/18/2004 | CA2493974A1 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | CA2493723A1 Methods of treatment of male erectile dysfunction |
| 03/17/2004 | EP1398037A2 Pharmaceutical formulations comprising a water-insoluble complex for sustained drug delivery |
| 03/17/2004 | EP1398033A2 Use of benzodiazepines for treating autoimmune diseases, inflammations, neoplasies, viral infections and atherosclerosis |
| 03/17/2004 | EP1397507A1 Methods and compositions for treating cardiovascular disease using 10218 |
| 03/17/2004 | EP1397489A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 03/17/2004 | EP1397385A2 Methods for treating disorders of the nervous and reproductive systems |
| 03/17/2004 | EP1397365A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 03/17/2004 | EP1397361A1 Carboline derivatives as pdev inhibitors |
| 03/17/2004 | EP1397357A2 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 03/17/2004 | EP1397355A1 Pyridyl cyanoguanidine compounds |
| 03/17/2004 | EP1397354A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
| 03/17/2004 | EP1397150A2 Somatostatin agonists |
| 03/17/2004 | EP1397126A2 Method of delaying ejaculation |
| 03/17/2004 | EP1012154B1 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 03/17/2004 | EP0891332B1 6-phenylpyridyl-2-amine derivatives |
| 03/17/2004 | CN1483035A Sulfamidothienopyrimidines |
| 03/17/2004 | CN1483034A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 03/17/2004 | CN1482921A Compositions of estrogen-cyclodextrin complexes |
| 03/17/2004 | CN1482916A Vaccine composite containing invert growth factor a |
| 03/17/2004 | CN1481887A Sperm-producing fluidification Capsule |
| 03/17/2004 | CN1481874A Capsule for fortifying kidney and nourishing qi and its preparation mehtod |
| 03/17/2004 | CN1481855A Yunan red drug tablet , its preparation method and use |
| 03/17/2004 | CN1481839A Medication for irregular menses and dysmenorrhea and preparation method |
| 03/17/2004 | CN1481803A Use for saponin of Chinese aralia in preparation of dysmenorrhea medication and antalgic medication |
| 03/17/2004 | CN1142182C Macroweb bombinator antisperm polypeptide and its preparation process and use in medicine |
| 03/17/2004 | CN1141971C Ointment for treating cracked nipple |
| 03/17/2004 | CN1141960C Traditional Chinese medicine composition applied via rectum and vagina for endometriosis and dysmenorrhea |
| 03/16/2004 | US6706753 Integrin receptor inhibitors |
| 03/16/2004 | US6706747 Treating elevated intraocular pressure, depression, non insulin-dependent diabetes, male impotence and obesity which is alleviated by treatment with an alpha 2 blocking agent |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/16/2004 | US6706700 Novel steroids containing a 14 beta ,15 beta - cyclopropane ring and a 17 alpha hydroxymethyl group; male contraceptives |
| 03/16/2004 | US6706682 Increasing or maintaining the blood supply in the penis |
| 03/16/2004 | CA2190847C Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/11/2004 | WO2004020414A1 Oxytocin inhibitors |
| 03/11/2004 | WO2004019954A1 Estrogen replacement regimen |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors |
| 03/11/2004 | WO2004009578A3 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 03/11/2004 | WO2003066585A3 Polymer-based compositions for sustained release |
| 03/11/2004 | WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | WO2002072802A3 Live attenuated strains of prrs virus |
| 03/11/2004 | US20040049083 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/11/2004 | US20040048919 Related to premenstrual syndrome, premenstrual dysphoric disorder, perimenopause, menopause, or side effects of hormonal contraceptives; combination of polyunsaturated fatty acid and tocopherol derivative, most of which is not alpha |
| 03/11/2004 | US20040048907 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/11/2004 | US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc. |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048812 Health supplement |
| 03/11/2004 | US20040048800 Use of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | DE20301728U1 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen 5-substituted 7,9-difluoro-5H-chromeno (3,4-f) quinoline compounds as selective progesterone receptor modulator compounds |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | CA2496887A1 Oxytocin inhibitors |
| 03/11/2004 | CA2495330A1 Estrogen replacement regimen |
| 03/10/2004 | EP1396271A1 Use of germination-activated ganoderma lucidium spores as anti-aging agent and against menopause symptoms |
| 03/10/2004 | EP1396255A1 Method for suppressing reduction of elasticity of skin |
| 03/10/2004 | EP1395593A1 Novel pyrazolopyrimidinethione derivatives. preparation methods thereof and their use as therapeutics for erectile dysfunction |
| 03/10/2004 | EP1395589A1 Imidazo-triazine derivatives as pde 5 inhibitors |
| 03/10/2004 | EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395563A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1236725B1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
| 03/10/2004 | EP1163244B1 Thienopyrimidine compounds, their production and use |
| 03/10/2004 | EP0980245B1 Use of misoprostol or/and misoprostol acid for the treatment of erectile dysfunction |
| 03/10/2004 | EP0804435B1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 03/10/2004 | CN1481388A 14(15)-unsturated 15-and/or 16-substituted androgens with mixed androgen-progestational profile |
| 03/10/2004 | CN1481244A Pharmaceutical formulation contg pyrazolo [4,3-D] pyrinidines, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481243A Pharmaceutical formulation contg. thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1480522A Medicinal wine compsn and its prepn. method |
| 03/10/2004 | CN1480212A Application of neurotoxin therapy in treatment of urinary system and relative diseases |
| 03/10/2004 | CN1480204A Preparation of Chinese herbal medicine for treating barrenness of women |
| 03/10/2004 | CN1480200A Penetrating fluid for acupuncture point of electrotherapeutics |
| 03/10/2004 | CN1480173A Chinese herbal medicine for treating gynecology disease and its preparing method |
| 03/10/2004 | CN1480151A Policresulen lotion |
| 03/10/2004 | CN1480150A Mammary gland membrane |
| 03/10/2004 | CN1141316C Gene sequence of genital regulation factor enriched in hypothalamus of epinephelus and its usage |